Gerresheimer (GXI) Given a €88.00 Price Target at Credit Suisse Group

Share on StockTwits

Credit Suisse Group set a €88.00 ($102.33) target price on Gerresheimer (ETR:GXI) in a research report released on Friday morning. The brokerage currently has a buy rating on the stock.

A number of other equities analysts have also recently commented on the stock. Hauck & Aufhaeuser set a €60.00 ($69.77) price objective on shares of Gerresheimer and gave the stock a sell rating in a research report on Wednesday, September 5th. Commerzbank set a €68.00 ($79.07) price objective on shares of Gerresheimer and gave the stock a neutral rating in a research report on Wednesday, August 29th. JPMorgan Chase & Co. set a €79.40 ($92.33) price objective on shares of Gerresheimer and gave the stock a neutral rating in a research report on Friday, July 6th. equinet set a €69.00 ($80.23) price objective on shares of Gerresheimer and gave the stock a neutral rating in a research report on Monday, September 24th. Finally, Independent Research set a €72.00 ($83.72) price objective on shares of Gerresheimer and gave the stock a neutral rating in a research report on Thursday. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and four have given a buy rating to the stock. The stock has an average rating of Hold and a consensus target price of €71.67 ($83.33).

GXI stock traded down €2.85 ($3.31) during midday trading on Friday, reaching €61.50 ($71.51). 389,276 shares of the company were exchanged, compared to its average volume of 140,925. Gerresheimer has a one year low of €59.97 ($69.73) and a one year high of €78.25 ($90.99).

Gerresheimer Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Further Reading: Intrinsic Value and Stock Selection

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply